IL33 and non-small cell lung carcinoma: For example, it was recently shown that monoclonal antibody blockade of IL-33 in mice xenografted with human non-small-cell lung carcinoma (NSCLC) decreased the accumulation of TREG cells and reduced macrophage M2 polarization, leading to the efficient inhibition of tumor growth (158).